Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on September 11, 2025
Sarat Ventures Y Innovations Biotech Fund investiert in Start-up-Unternehmen mit Schwerpunkt auf Saudi-Arabien und der MENA-Region
LONDON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- In einem historischen Schritt zur Positionierung Saudi-Arabiens als globaler Knotenpunkt für Biotechnologie gab Sarat Ventures Y Innovations Biotech Fund (UK) heute die Auflegung eines Biotech-Fonds bekannt, der …
Le fonds Sarat Ventures Y Innovations Biotech Fund prévoit d’investir dans des entreprises en phase de démarrage, plus particulièrement en Arabie saoudite et dans la région MENA
LONDRES, 11 sept. 2025 (GLOBE NEWSWIRE) -- Dans le cadre d’une initiative historique visant à positionner l’Arabie saoudite comme un pôle mondial de la biotechnologie, le fonds Sarat Ventures Y Innovations Biotech Fund (Royaume-Uni) a annoncé aujourd’hui …
Sarat Ventures Y Innovations Biotech Fund invertirá en empresas en etapa inicial con enfoque en Arabia Saudita y en la región MENA
LONDRES, Sept. 11, 2025 (GLOBE NEWSWIRE) -- En un paso histórico hacia el posicionamiento de Arabia Saudita como un centro mundial de biotecnología, Sarat Ventures Y Innovations Biotech Fund (Reino Unido) anunció hoy el lanzamiento de un fondo de …
קרן הביוטק Sarat Ventures Y Innovations תשקיע בחברות בשלבים מוקדמים עם דגש על ערב הסעודית ואזור המזרח התיכון וצפון אפריקה
לונדון, Sept. 11, 2025 (GLOBE NEWSWIRE) -- בצעד היסטורי לקראת מיצוב ערב הסעודית כמרכז עולמי לביוטכנולוגיה, Sarat Ventures Y Innovations Biotech Fund (בריטניה) הודיעה היום על השקת קרן ביוטכנולוגיה, המעוגנת על ידי Allocator One, שצפויה להשקיע כ-50 מיליון …
サラット・ベンチャーズYイノベーションズ・バイオテック・ファンド (Sarat Ventures Y Innovations Biotech Fund)、サウジアラビアおよび中東・北アフリカ地域を中心とした初期段階の企業へ投資
ロンドン発 , Sept. 12, 2025 (GLOBE NEWSWIRE) -- サウジアラビアをバイオテクノロジーの世界的拠点として位置付けるための歴史的な一歩として、サラット・ベンチャーズYイノベーションズ・バイオテック・ファンド (英国) は本日、アロケーター・ワン (Allocator One) を中核とするバイオテック・ファンドの設立を発表した。同ファンドは、サウジアラビア市場および周辺の中東・北アフリカ (MENA) 地域との戦略的つながりを持つバイオテクノロジー企業に対し、約5,000 …
Sarat Ventures Y Innovations Biotech Fund, 사우디아라비아 및 MENA 지역 중심의 초기 단계 기업에 투자
런던, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 사우디아라비아를 글로벌 바이오테크 허브로 자리매김하기 위한 역사적 행보의 일환으로 Sarat Ventures Y Innovations Biotech Fund (UK)가 오늘 바이오테크 펀드의 출범을 발표했다. 이 펀드는 Allocator One이 앵커 투자자로 참여하며, 사우디아라비아 시장 및 광범위한 MENA(중동·북아프리카) 지역과 전략적 연계가 있는 바이오테크 기업들에 약 5천만 …
Sarat Ventures Y Innovations Biotech Fund akan Melabur dalam Syarikat Peringkat Awal di Arab Saudi dan Rantau MENA
LONDON, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Dalam satu langkah bersejarah ke arah menjadikan Arab Saudi sebagai hab global dalam bidang bioteknologi, Sarat Ventures Y Innovations Biotech Fund (UK) hari ini mengumumkan pelancaran dana bioteknologi baharu …
Sarat Ventures Y Innovations Biotech Fund Irá Investir em Empresas em Estágio Inicial com Foco na Arábia Saudita e na região MENA
LONDRES, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Em um passo histórico para posicionar a Arábia Saudita como um centro global de biotecnologia, o Sarat Ventures Y Innovations Biotech Fund (Reino Unido) anunciou hoje a criação de um fundo de biotecnologia, …
Sarat Ventures Y Innovations Biotech Fund将重点投资沙特阿拉伯及中东和北非地区初创企业
伦敦, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 为推动沙特阿拉伯成为全球生物技术枢纽迈出历史性一步，Sarat Ventures Y Innovations Biotech Fund (UK)今日宣布推出生物技术基金，该基金由Allocator One主导，预计将向与沙特阿拉伯市场及更广泛的中东和北非地区具有战略联系的生物技术公司投资约5000万美元。 这项倡议由Y Innovations Group旗下子公司Yung Ventures的普通合伙人Megan Yung …
Sarat Ventures Y Innovations 生物科技基金致力投資初創企業，重點關注沙特阿拉伯及中東和北非 (MENA) 地區
倫敦, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 在將沙特阿拉伯打造為全球生物科技中心的歷史性進程中，Sarat Ventures Y Innovations 生物科技基金（英國）今日宣佈成立由 Allocator One 領銜的生物科技基金，預計將向與沙特阿拉伯市場及更廣泛中東和北非地區具策略連繫的生物科技公司投資約 5,000 萬美元。 此計劃由 Y Innovations 集團公司 Yung Ventures 的 Megan Yung …
Dayforce Named a Leader in the 2025 Gartner® Magic Quadrant™ for HCM Suites for 1,000+ Employee Enterprises for Sixth Consecutive Year
MINNEAPOLIS and TORONTO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced it has been named a Leader in the 2025 Gartner Magic Quadrant for …
Global Brain Imaging Devices Market is Projected to Grow at a CAGR of ~6% by 2032 | DelveInsight
New York, USA, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Global Brain Imaging Devices Market is Projected to Grow at a CAGR of ~6% by 2032 | DelveInsight The brain imaging devices market is experiencing significant growth, fueled by the increasing incidence of …
Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight
New York, USA, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight The bipolar disorder clinical trial landscape is evolving with 25+ therapies, namely, KarXT (BMS …
Aligned Data Centers Donates $100,000 to mikeroweWORKS Foundation, Championing Skilled Trades and Future Workforce Development
DALLAS, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Aligned Data Centers (“Aligned” or the “Company”), a leading provider of Gigascale, Build-to-Scale, and Multi-tenant data center solutions supporting hyperscale, neocloud, and enterprise customers' most demanding …
ASUS Listed on TIME’s World’s Best Companies 2025 for the Second Time
KEY POINTS TIME recognition: ASUS secures its second inclusion on TIME’s World’s Best Companies that set the standard in innovation, growth, employee satisfaction A commitment to innovation: ASUS validated for its leadership in fostering a great workplace, …
iPhone 17 Protection, Built for You, From Urban Armor Gear
Irvine, California, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Orange County, Calif. (Sept. 9th, 2025) – Urban Armor Gear (UAG), leading designer of rugged, lightweight mobile device cases, power and accessories, is excited to announce the launch of its latest …
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer A total of 105 HLA-A2 positive …
OSE Immunotherapeutics et la Fondation FoRT annoncent la fin du recrutement dans Combi-TED, l’étude clinique de Phase 2 évaluant Tedopi® en combinaison avec nivolumab ou docétaxel dans le cancer du poumon non à petites cellules
OSE Immunotherapeutics et la Fondation FoRT annoncent la fin du recrutement dans Combi-TED, l’étude clinique de Phase 2 évaluant Tedopi® en combinaison avec nivolumab ou docétaxel dans le cancer du poumon non à petites cellules Un total de 105 patients HLA …
Lightcast and Carahsoft Partner to Bring Data-Driven Workforce Strategies to the Public Sector
MOSCOW, Idaho, and RESTON, Va., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Lightcast, a global leader in labor market analytics, and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, today announced a partnership. Under the agreement, …
Mount Pleasant Group Becomes First in Canada to Offer Mushroom-Grown Coffins and Urns from Loop Biotech
Toronto, Sept. 11, 2025 (GLOBE NEWSWIRE) -- In a Canadian first, Mount Pleasant Group (MPG) is proud to introduce the Loop Living Cocoon™ and Loop EarthRise™, revolutionary biodegradable funeral products grown from mushrooms. These nature-powered …